Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach

Oncogene

Volumn 25, Issue 18, 2006, Pages 2628-2635

  Li, R ^a   Wang, H ^a   Bekele, B N ^a   Yin, Z ^b   Caraway, N P ^a   Katz, R L ^a   Stass, S A ^c   Jiang, F ^c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Lung cancer; Microarrays; Proteomics; Tissue microarray

Indexed keywords

KI 67 ANTIGEN; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CALR GENE; CANCER CELL CULTURE; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; EEF1A2 GENE; FLUORESCENCE IN SITU HYBRIDIZATION; FUNCTIONAL GENOMICS; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KCIP 1 GENE; LUNG ADENOCARCINOMA; MASS SPECTROMETRY; MICROARRAY ANALYSIS; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; ONCOGENE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRDX1 GENE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; SOUTHERN BLOTTING; VALIDATION PROCESS; WESTERN BLOTTING;

ADENOCARCINOMA; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMICS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENES; PEPTIDE ELONGATION FACTOR 1; RNA, SMALL INTERFERING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TISSUE ARRAY ANALYSIS; TUMOR CELLS, CULTURED;

EID: 33646368154     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209289     Document Type: Article

References (19)

1. Anand N, Murthy S, Amann G, Wernick M, Porter LA, Cukier IH et al. (2002). Nat Genet 31: 301-305.
2. Barrett MT, Scheffer A, Ben-Dor A, Sampas N, Lipson D, Kincaid R et al. (2004). Proc Natl Acad Sci USA 101: 17765-17770.
3. Chen G, Gharib TG, Huang CC, Taylor JM, Misek DE, Kardia SL et al. (2002). Mol Cell Proteomics 1: 304-313.
4. Hyman E, Kauraniemi P, Hautaniemi S, Wolf M, Mousses S, Rozenblum E et al. (2002). Cancer Res 62: 6240-6245.
5. Jiang F, Caraway NP, Li RY, Katz RL. (2005). Oncogene 24: 3409-3418.
6. Jiang F, Lin F, Price R, Gu J, Medeiros LJ, Zhang HZ et al. (2002). J Mol Diagn 4: 144-149.
7. Jiang F, Yin Z, Caraway NP, Li R, Katz RL. (2004). Neoplasia (New York) 6: 623-635.
8. Kim HJ, Chae HZ, Kim YJ, Kim YH, Hwangs TS, Park EM et al. (2003). Cell Biol Toxicol 19: 285-298.
9. Lee JM. (2003). Reprod Biol Endocrinol 1: 69-73.
10. Luk C, Tsao MS, Bayani J, Shepherd F, Squire JA. (2001). Cancer Genet Cytogenet 125: 87-99.
11. Martin B, Paesmans M, Mascaux C, Berghmans T, Lothaire P, Meert AP et al. (2004). Br J Cancer 91: 2018-2225.
12. Oates J, Edwards C. (2000). Histopathology 36: 341-347.
13. Pollack JR, Sorlie T, Perou CM, Rees CA, Jeffrey SS, Lonning PE et al. (2002). Proc Natl Acad Sci USA 99: 12963-12968.
14. Qi W, Liu X, Qiao D, Martinez JD. (2005). Int J Cancer 113: 359-363.
15. Ross JS, Fletcher JA. (1999). Semin Cancer Biol 9: 125-138.
16. Shen J, Person MD, Zhu J, Abbruzzese JL, Li D. (2004). Cancer Res 64: 9018-9026.
17. Thomas D, Guthridge M, Woodcock J, Lopez A. (2005). Curr Top Dev Biol 67: 285-303.
18. Tonon G, Wong KK, Maulik G, Brennan C, Feng B, Zhang Y et al. (2005). Proc Natl Acad Sci USA 102: 9625-9630.
19. Wang H, Zhang Z, Li R, Ang KK, Zhang H, Caraway NP et al. (2005). Int J Cancer 116: 285-290.